Early cellular and molecular events in inflamed skin include the active participation of epidermal keratinocytes (KCs) and dermal mast cells which can produce diffusible mediators such as tumor necrosis factor-alpha (TNF-a), histamine, and urocanic acid (UCA). Rapid induction of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) by KCs is observed following a highly diverse array of stimuli which can provoke both irritant, inflammatory, as well as allergic and immune reactions. To determine if the aforementioned mediators could interact in either an additive or synergistic fashion with each other, cultured KCs were exposed to these mediators alone and in combination, and the degree of ICAM-1 mRNA and protein quantitated. Whereas histamine or cis-UCA alone only weakly induced KC ICAM-1, when they were combined with TNF-a, significant augmentation was observed by Northern blot hybridization studies, immunostaining, and FACS analysis. Other histamine derivatives such as L-histidine, 1 methylhistidine, 3-methylhistidine, or all-trans-UCA had no effect. Histamine pretreatment did not affect cell surface high affinity TNF-a receptors, as determined by ligand binding and immunodetection, and did not induce KC TNF-a production. The KC histamine receptor was also characterized and found not to be influenced by TNF-a, cis-UCA, all-trans-UCA, or diphenyhydramine (an H, antagonist), but it was inhibited by cimetidine (an H, antagonist). These results demonstrate that 1) KCs can be induced to express ICAM-1 by exposure to histamine and cis-UCA, 2) histamine and cis-UCA can also augment TNF-a inducible ICAM-1 mRNA and cell surface protein expression, 3) this augmentation does not directly involve changes in KC TNF-a receptor number, affinity, or TNF-a production and, 4) KCs possess a type 2 histamine receptor which is not the photoreceptor for UCA. These findings highlight the potential for cross-talk between molecules produced by resident cutaneous cell types above (i.e., KCs) and below (i.e., mast cells) the epidermal basement membrane zone. These cel Is and their mediators can cooperate to respond to either exogenous or endogenous stimuli leading to rapid and strong KC ICAM-1 expression. Such induction of this important adhesion molecule by KCs ensures the retention of T lymphocytes necessary to participate in the maintenance of cutaneous immunohomeostasis. o 1993 Wiiey-Liss, Inc.
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In 1927 Sir Thomas Lewis proposed that the "triple response" of the skin following a wide variety of injurious stimuli was mediated by the appearance of a soluble product in the immediate neighborhood of affected epidermal cells that he termed the "H-substance" (Lewis, 1927) . Ten years earlier, it had been demonstrated that histamine injection into human epidermis produced capillary dilatation and whealing. Eventually it was recognized that histamine was a potent local vasodilator, and that the H-substance and the mast cell derived histamine were identical (reviewed in Dale, 1929) . In 1991, Barker et al. postulated that keratinocytes (KCs) could initiate cutaneous inflammation following a wide variety of injurious stimuli by their production of the cytokine, tumor necrosis factor-alpha 0 1993 WILEY-LISS, INC.
(TNF-a). Thus, both mast cells and KCs may function as instigators of cutaneous inflammation via their production of diffusible molecular mediators. While there is a growing interest in the role of histamine in immu-nological reactions, which complement its previous role in inflammation, there are relatively few reports that have explored the potential positivehegative interaction between histamine and immunomodulatory cytokines such as TNF-a (reviewed in Falus and Meretey, 1992) . Also, another histamine related compound known as urocanic acid (UCA) has gained increasing attention for its immunomodulatory role in skin diseases (Noonan and DeFabo, 1992) .
In this report, we asked whether there are any synergistic effects between histamine, UCA, and TNF-a with respect to the induction of KC intercellular adhesion molecule-1 (ICAM-1; CD-54) expression. KC ICAM-1 expression was chosen for study because it is rapidly induced (within 24-48 hr) in a variety of irritant and allergic contact dermatitis reactions (reviewed in Nickcdoff, 1992) . Moreover, following the epicutaneous application of the poison ivy antigen-urushiol, KC ICAM-1 expression actually precedes any significant trafficking of bloodstream derived mononuclear leukocytes, suggesting that endogenously derived mediators produced by locally resident cutaneous cells are capable of triggering this epidermal immunomodulatory event (Griffiths and Nickoloff, 1989) . In this report, we demonstrate that histamine or cis-UCA can directly induce EL relatively low level of KC ICAM-1 expression, but when histamine or cis-UCA is combined with TNF-a, hoth further augment the induction of ICAM-1.
MATERIALS AND METHODS
KC culture Using a Castroveijo keratome, primary KC cultures were obtained from normal-appearing skin of healthy adult volunteers without any skin disease and not on any medication. All volunteers gave written informed consent, with approval by the Human Subjects Committee of the University of Michigan. A single cell suspension was prepared as previously described (Griffiths et al., 1989) . Freshly isolated epidermal cells were seeded into 35 mm polystyrene tissue culture dishes (Corning Glass Works, Corning, NY) and grown in the presence of a low calcium (0.15 mM) serum free medium containing epidermal growth factor (EGF, 10 ngi nnl), insulin (5 pg/ml), hydrocortisone (0.5 pg/ml), and bovine pituitary extract 0.4% vlv, designated KGM (Clonetics Corporation, San Diego, CAI. Culture dishes were incubated in a humidified atmosphere containing 5% CO, at 37°C and the KCs were routinely passaged by using 0.03% trypsin/O.Ol% ethylenediaminetetraacetic acid (EDTA) to disperse the semiconfluent monolayer of cells, and used between passage numbers 2 and 3.
Treatments of KC cultures Semiconfluent KC cultures were always used for treatment with histamine (and its derivatives) or 7°F-a, and the treatment was continued for 48 hr. Ftecombinant human TNF-a was obtained from Genentech Inc., South San Francisco (specific activity = 1.7 x lo7 U/mg); histamine, L-histidine, l-methy lhistidine, and 3-methylhistidine were purchased firom Sigma Chemical Corp., St. Louis, MO. The concentration of histamine or TNF-a is stated in the appropriate table or figure. Bioactivity and detection of TNF-a in conditioned medium which can detect as little as 10 pg/ml were measured by cytolysis of WEHI cells (courtesy of Dr. D. Remick; University of Michigan) as previously described (Eskandari et al., 1990 ). All-trans-UCA was purchased from Sigma. Cis-UCA was prepared by ultraviolet-B (UV-B) irradiation of the trans-isomer. Briefly, 3 ml of a 5 mg/ml stock solution of all-trans-UCA was placed into a 60 cm Petri dish and UV-B irradiated using a bank of four Westinghouse FS-40 fluorescent lamps a t a distance of 1 cm above the dish. The intensity of the UV-B a t the level of the liquid was measured using a radiometer (International Light Inc., Newburgport, MA). Under these conditions, the light source delivered over a 30-min irradiation interval a total UV-B dose of 300 mJ/cm2. While there was no detectable cis-UCA initially as determined using paper chromatography (Baden et al., 19661 , after irradiation there were approximately equal amounts of cis-UCA and trans-UCA, as previously described (Ross et al., 1986) . The irradiated solution was stored at 4"C, and periodically checked by paper chromatography to verify the presence of cis-UCA. For each result, the concentration of cis-UCA was determined by dividing the initial all-trans-UCA concentration in half.
Cell immunostaining
To analyze constitutive expression and induction of ICAM-1 (anti-ICAM-1 monoclonal antibody [mAbl RRli1; gift of Dr. T. Springer, Boston, MA) and class I1 major histocompatibility complex (MHC) (anti-HLA-DR mAb; L243; Becton-Dickinson, Mountain View, CA) on cultured cells by the various treatments, cells were detached from plastic dishes using 0.03% trypsin/O.Ol% EDTA, with indirect immunofluorescence staining, followed by fluorescence-activated cell sorter (FACS) analysis as previously described (Griffiths et al., 1989) . Antibody against the 55-60 kDa form of the TNF-a receptor was obtained from Genzyme Corp., Boston, MA. Isotype control (Leu 2a, IgG; Becton-Dickinson) immunoreactivity was also measured. In addition to FACS analysis of single cell suspension, KCs were grown in 8-well tissue culture chamber slides (Lab-Tek, Nunc Inc., Naperville, IL). After various treatments, cell monolayers were fixed with cold acetone for 10 min, air dried at room temperature, and then stained for ICAM-1 using a sensitive avidin-biotin-peroxidase technique (Vectastain Kit, Vector Laboratories, Burlingame, CA) as described previously (Griffiths and Nickoloff, 1989) .
Northern blot hybridization RNA from monolayers of untreated or treated KC was extracted with guanidine hydrochloride (5.7 M), potassium acetate (100 mM, pH L O ) , sonicated on ice for 60 sec, ethanol precipitated, and centrifuged at 15,OOOg for 30 min a t 4°C as previously described (Barker et al., 1990) . Ten to 15 pg total cellular RNA was separated on 1% agarose gels containing 2.2 M formaldehyde and electroblotted on nytran membranes (Schleicher and Schuell, Keene, NH). The cDNA probe for ICAM-1 was cloned by differential hybridization as described elsewhere (Eskandari et al., 19901 , and the cDNA probe for TNF-a was purchased from American Type Culture Center, Rockville, MD. Cyclophilin cDNA probe (obtained from C. Griffiths, University of Michigan) was used to measure constitutive gene activity because it is known to be minimally altered in cultured KCs (Barker et al., 1990) . Each insert was purified by agarose gel electrophoresis and electroelution and 32P labeled by the random primer method. Nytran membranes were hybridized overnight, washed in 0.3 M sodium chloride, 0.03 M sodium citrate, and 1% sodium dodecyl sulfate (SDS) at 65°C and subjected to autoradiography. The results indicated are representative of blots obtained in three separate experiments using KCs isolated from different donors. The relative density of the signals from each lane of the Northern blots was determined by scanning laser densitometry as previously described for the quantitation of mRNA (Barker et al., 1990) .
Ligand binding a s s a y l"I-rTNF-a was purchased from New England Nuclear (NEN) Research Products, Wilmington, DE (specific activity, 44.9 pCi/pg). In a standard binding assay, approximately 2-2.5 x lo5 untreated or histamine andlor TNF-a treated KCs in 24-well plates were washed twice with KBM at 37°C over a 3-hr time interval. The cells were washed once with Earle's balanced salt solution (EBSS) containing 1% bovine serum albumin (binding assay medium) (radioimmunoassay [RIA] grade, Sigma). The cells were chilled on ice bath and then incubated with 0.5 ml of binding assay medium and varied concentrations of 1251-TNF-a (0.015-0.525 nM). The cultures were maintained at 4°C for the duration of binding assay (usually 4 h r unless otherwise specified). The binding assay was terminated by washing the monolayers three times with ice-cold binding medium. Solubilization of cells was accomplished using 1 ml of 0.1 N sodium hydroxide containing 1% SDS and counted in a gamma counter. Nonspecific binding was determined by adding 200-fold excess of unlabeled TNF-a to parallel sample wells and was no greater than 25% of the total amount bound under any treatment conditions. Data points represent the average of duplicate samples with nonspecific binding subtracted. Each figure represents the mean of three separate experiments.
The uptake of labeled histamine by untreated or TNF-a treated cells was measured by following the published procedure (Haddock et al., 1987) . Tritiumlabeled histaine hydrochloride (specific activity = 26.4 Ciimmol) was purchased from NEN Research Products.
Cells were incubated at 37°C for 2 h r with 0.038 p M [3H] histamine in KGM medium containing 20% fetal bovine serum. Incubation was terminated by chilling on ice and washing the monolayer three times with cold Dulbecco's phosphate-buffered saline. Solubilization of the cells was accomplished using 0.25 N sodium hydroxide followed by liquid scintillation counting. To study the effect of histamine receptor antagonists on cellular uptake of histamine, cells were exposed to cimetidine and diphenhydramine (Sigma) a t the indicated concentration shown in Table 1 . A stock solution of 0.1 M cimetidine in 50% dimethyl sulfoxide (DMSO) or 0.1 M diphenhydramine was prepared in KGM. Each was diluted just before use with KGM to give appropriate concentration. The potential ability of histamine to induce KC ICAM-1 was screened by performing immunostaining of intact semiconfluent monolayers. In the absence of any addition to the KGM medium, only a rare isolated KC (less than 1 of 100 cells) was ICAM-1 positive (Fig.  la) . Upon addition of TNF-a (50 U/ml; 48 hr), numerous KCs became ICAM-1 positive (Fig. lb) . When KC cultures were exposed to 5 mM histamine, there was also a n increase in the number of ICAM-1-positive cells (Fig. lc) , which was substantially increased when a combination of TNF-u plus histamine was used (Fig.  Id) . These positive direct KC responses to histamine led us to explore the potential ability of other histamine derivations to induce ICAM-1, either alone, or in combination with a low concentration of TNF-a. There was no induction of KC ICAM-1 by L-histidine, l-methylhistidine, 3-methylhistidine, or all-trans-UCA when used as a single agents (data not shown).
In the presence of TNF-a, these same three compounds failed to either inhibit or increase in an additive or synergistic manner KC ICAM-1 expression. However, when a UV-B irradiated 5 mM solution of alltrans-UCA was used (which contained approximately a 50% mixture of cis-UCA), KC ICAM-1 was induced in a similar manner as histamine (data not shown). TO quantitate more precisely these aforementioned results, single cell suspensions were prepared and cell surface expression determined by FACS analysis. Figure 2 reveals a representative FACS analysis for KCs treated for 48 h r with either KGM alone; TNF-a (500 U/ml); histamine (0.5 mM); and the combination of TNF-a (500 U/ml) plus histamine (0.5 mM). The solid profile areas reveal that there is a synergistic induction of KC ICAM-1 by the combination of TNF-a plus histamine, compared to the results using these molecules singly, in agreement with the immunostaining results portrayed in Figure 1 . This synergistic reaction was specific for ICAM-1, as no change in KC HLA-DR expression was noted compared to the isotype control (portrayed by the open profile areas in the upper panels of Fig. 2) . Figure 3 summarizes a representative experiment in which the effects of various concentrations of both TNF-a and histamine were used. Below 0.1 mM histamine had no significant effect, but by 0.5 mM, a consistent increase in ICAM-1 expression was detected. As shown in the Figure 3C combining TNF-a (500 U/ml) with increasing concentrations of histamine resulted in a marked synergistic induction of KC ICAM-1. Similar FACS analysis failed to reveal any influence on KC ICAM-1 (with or without TNF-a) for the same four compounds described above by immunostaining (L-histidine, l-methylhistidine, 3-methylhistidine, all-trans-UCA; data not shown). The ability of the cis-UCA preparation to induce ICAM-1 is shown in . On the right side, KC ICAM-1 expression induced by either histamine (5 mM) or cis-UCA is presented, both without or with TNF-a (500 U/ml). The combination of histamine or cis-UCA with TNF-a (500 U/ml) produced approximately the same FACS profile as did the TNF-a (1,000 U/ml) for ICAM-1 expression. The mean channel fluorescence intensity values are as follows: No TNF-a = 3; TNF-a (50 U/ml) = 9; TNF-a (100 U/ml) = 16; TNF-a (500 U/ml) = 26; TNF-a (1,000 U/ml) = 33; histamine alone (5 mM) = 8; cis-UCA alone (2.4 mM) = 7; histamine plus TNF-a (500 U/ml) = 38; cis-UCA plus TNF-a (500 Uiml) = 35. It should be noted that these levels of ICAM-1 expression using TNF-a are relatively low compared to the ability cf interferon gamma (IFN-y) alone (20 U/ml) to induce ICAM-1 (value = 164) in agreement with a previous report (Norris et al., 1990) .
Induction of KC ICAM-1 by FACS analysis
Induction of KC ICAM-1 mRNA b y Northern blot hybridization To determine whether the synergistic interaction between histamine and TNF-a with respect to KC ICAM-1 expression was related to transcriptional events, Northern blot hybridization studies were performed. As previously observed, KCs produce ICAM-1 mRNA transcripts after 6 h r of stimulation with cytok.ines such as IFN--y and TNF-a (Fig. 5a ). In untreated EiC cultures, no significant ICAM-1 mRNA was detectable, and the IFN--y (500 U/ml) induction of ICAM-1 nnRNA served as a positive control. Using histamine alone at 0.05 mM and 0.10 mM, no significant ICAM-1 rnRNA was detectable in agreement with the cell surface detection by FACS analysis a t the protein level (Fig. 3) . Combining TNF-a (500 U/ml) with histamine (0.05 or 0.1 mM) produced increased ICAM-1 mRNA compared to TNF-a alone. This augmentation in ICAM-1 mRNA was synergistic at the mRNA level (as determined by laser densitometry analysis of the Northern blot, Fig. 5b ) which is in agreement with the protein expressed at the cell surface as detected by FACS analysis. Cyclophilin mRNA results confirm equivalent loading of samples per well. Figure 6 reveals that combining cis-UCA (1 mM) with TNF-a (500 Ulml) also increased ICAM-1 mRNA above that induced by either molecule used signly. To determine whether the induction of KC ICAM-1 by histamine was related to increased TNF-a production by KCs, two experimental approaches were utilized. First, conditioned medium for KC supernatants was collected after 6 and 24 h r of addition of histamine (5 mM) to KGM. However, no TNF-a bioactivity was detected using a highly sensitive bioassay in the conditioned media before or after addition of histamine (data not shown). In the second approach, TNF-a mRNA transcripts were examined by northern blot hybridization. Figure 7 reveals that at 6 and 18 h r after addition of histamine (5 mM), no TNF-a transcripts were identified. As previously observed (Barker et al., 1990) , TNF-a autoinduces the detection of TNF-a mRNA transcripts i n cultured KCs, and in some experiments the combination of histamine plus TNF-a further increased the detection of TNF-a mRNA transcripts. Whether this increased amount of TNF-a mRNA transcripts was accompanied by a concomitant increase in translated and secreted protein could not be determined because of the cross-reactivity in the bioassay between the added exogenous recombinant TNF-a and the naturally produced TNF-a.
Measurement of TNF-a surface receptors b y ligand binding and FACS analysis To determine whether the marked increase in ICAM-1 induction was due to the alteration of TNF-a receptor number or affinity in the presence of histamine, surface binding of labeled TNF-a was next carried out. Figure 8 shows a time course of TNF-a binding to confluent cultures of KCs a t 4°C. Results show that specific binding (total binding minus nonspecific binding which was determined by including 200-fold excess nonlabeled TNF-a) reached a plateau between S 1 2 hr in agreement with a previous report (Pillai et al., 1989) . At 37"C, the maximal binding was achieved by 3 hr (data not shown). However, at 37"C, a considerable cell associated radioactivity was internalized (Pillai et al., 1989) . Also the extent of degradation of labeled TNF-a was minimal a t 4°C (Pillai et al., 1989) . Hence, all the binding assays with '"I-TNF-a were carried out at 4°C for 6 6 hr. KCs in culture treated with 5.0 mM histamine for 48 hr, or untreated cultures were washed and used for 1251-TNF-a binding studies. The specific binding to KCs increased with increasing concentrations of labeled TNF-a and achieved saturation with and without histamine between 0.4 and 0.55 nM (Fig. 9a) . Using histamine at 5.0 nM concentration which did not inhibit KC proliferation or alteration in morphology, no difference in lZ5I-TNF-a binding was observed (Fig. 9a) . Scatchard plot analysis of the ligand binding data yielded linear plots (regression coefficient = 0.9) indicating the presence of a single class of high affinity binding sites (Fig. 9b) . The dissociation constant for histamine treatment or non-treated cell was calculated to be 0.25 t 0.03 nM with 1,600 k 150 receptor sites per KC. Neither the number of receptors per cell nor the affinity constant for TNF-a was altered by includ- ing 0.1 mM histamine in binding assay medium or by exposing KCs to a much higher concentration of histamine such as 2 mM. By FACS analysis, KC cell surface immunostaining for the 55-60 kDa TNF-a receptor revealed a single peak with a mean channel fluorescence value of 18 (isotype control value = 4). Pretreating the KCs for 24 hr with either histamine (5 mM) or cis-UCA (2.5 mM) did not significantly change the FACS profile (data not shown).
Characterization of 3H-histamine binding to KCs
While histamine did not modulate the affinity or number of TNF-or receptors, we asked the reciprocal question; does TNF-a modulate histamine binding? Because no Drevious studies have been Dublished detailing the adility of histamine to bind akd stimulate KCs, ing 3H-histamine. Uptake of histamine in KCs was observed when the binding studies were carried out at we explored appropriate ligand binding parameters us- (Haddock et al., 1987) when ["HI histamine uptake was studied with human vascular endothelial cells.
KCs were incubated with 0.03 pM r3H1 histamine in the presence of different concentrations of unlabeled histamine and cell associated radioactivity was determined. The results of competition analysis demonstrate the specificity of binding between unlabeled and labeled histamine (Table 1) . At 200 IJ.M of unlabeled histamine, the binding was reduced by 70%. Table 1 compares the influence of TNF-a, diphenhydramine (H, antagonist), and cimetidine (H, antagonist) on L3H1 histamine uptake. With TNF-a pretreated KCs (500 U/ml for 24 hr), or inclusion of TNF-a in the binding medium, volved. In contrast, the inability of the antagonist diphenhydramine to inhibit labeled histamine uptake by KCs suggests that H, receptors do not play a significant role in the observed uptake. Failure to inhibit the uptake of t3H1 histamine by all-trans-UCA or its cis isomer even at higher concentration indicates that UCA uptake in KCs is not mediated through the histamine receptor.
DISCUSSION
The earliest inflammatory and immunological responses in skin can be viewed as the result of a cascade of molecular mediators produced by several different resident cell types. In this study, we focused on three such mediators produced by KCs and/or mast cells; i.e., TNF-a, UCA, and histamine. TNF-a is being recognized as a key cytokine in several common cutaneous disorders such as allergic and irritant contact dermatitis, and in UV-B induced tolerance to epicutaneous haptens (Barker et al., 1991; Griffiths et al., 1991; Piquet et al., 1991; Vermeer and Streilein, 1990) . While a previous study suggested that mast cell derived proinflammatory mediators together with TNF-a were important in the development of a cellular inflammatory response (via induction of endothelial cell adhesion molecules), it was not clear whether histamine and TNF-a could syn-ergize in such reactions (Klein et al., 1989) . Moreover, while the rapidly evolving dissection of the immunomodulatory properties of UV-B have increasingly centered on TNF-a, and the isomerization of all-trans-UCA to cis-UCA (reviewed in Noonan and DeFabo, 1992) , no previous study specifically addressed whether cis-UCA plus TNF-cr could augment KC ICAM-1 expression.
The current data indicate that both histamine and cis-UCA can directly induce KC ICAM-1 expression, albeit rather weakly in comparison with either TNF-a or IFN-7. However, both histamine and cis-UCA, when combined with TNF-a, significantly augment KC ICAM-1 expression (at the mRNA and protein level), without influencing class I1 MHC (i.e., HLA-DR) expression. Other histamine related compounds such as L-histidine, 1-methylhistidine, 3-methylhistidine, and all-trans-UCA lacked any capacity, when used either singly or in combination with TNF-a, to influence KC ICAM-1 expression. The interaction between histamine and cis-UCA with TNF-a did not involve detectable changes in either the number or affinity of either the TNF-a receptor or the histamine receptor. TNF-a receptor expression was characterized by both ligand binding with Scatchard analysis, as well as by flow cytometry. The affinity constant and number of receptors determined in our laboratory (0.25 nM; 1,600 sites per cell) are in good agreement with a previous group of investigators (0.28 nM; 1,250 sites per cell; Pillai et al., 19891 , as was our cell surface immunodetection for the epithelial type (i.e., 55-60 kDa) of the TNF-a receptor (Hohmann et al., 1989; Trefzer et al., 1991) . The ability of histamine to induce ICAM-1 expression was not accompanied by any detectable increase in KC production of TNF-a as measured at the mRNA or functional protein level in the conditioned medium. However, it is possible that both histamine and cis-UCA can induce a small increase in TNF-a which immediately bound to unoccupied high affinity cell surface receptors. Experiments utilizing polymerase chain reaction technology to detect relatively small changes in transcriptional events may be useful in this regard. It should be noted that a previous group investigating the action of IFN-)I plus TNF-a also could not correlate the synergistic response of the KCs to IFN-? with any detectable change in TNF-a receptor expression (Trefzer et al., 1991) .
With respect to the KC cell surface receptors for histamine, it appears that KCs possess a type 2 receptor because 3H-histamine binding was inhibited by cimetidine (an H2 receptor antagonist) but not by diphenhydramine (an HI receptor antagonist). The functional response of some cell types bearing H2 receptors involves activation of phospholipase C (reviewed in Mitsuhashi and Payan, 1992) and we have previously observed that ICAM-1 but not HLA-DR can be induced by phorbol ester which is a protein kinase C activator (Griffiths et al., 1990) . Thus, histamine may augment TNF-(r mediated IC AM-1 expression by postreceptor binding events such as second messenger systems involving phospholipase Uprotein kinase C. Moreover it appears that with monocytes, histamine can suppress TNF-ol production via H, receptors, and this may serve as a negative feedback loop to prevent excessive TNF-ol production by both recruited blood derived monocytes, as well as KCs within a skin site undergoing an inflammatory or immunological reaction (Vannier et al., 1991) . Because neither cis-UCA nor trans-UCA influenced %-histamine binding, it appears that the photoreceptor for UV-B light on KCs (i.e., cis-UCA receptor) is not the histamine receptor. A previous study reported that the immunosuppressive effects of UV-B, as measured by reduction in epidermal Langerhans cell numbers, was blocked by a type 1 histamine receptor antagonist such as terfenadine, as well as by a type 2 receptor antagonist such as cimetidine (Norval et al., 1990) . Thus, Langerhans cells may possess a histamine-like photoreceptor for UCA different from the KC photoreceptor, which is not influenced by histamine receptor antagonists.
Our data indicate that during the evolution of a cutaneous inflammatory reaction, important cross-talk may occur between epidermal KCs and dermal mast cells involving soluble mediators such as TNF-cr, histamine, and cis-UCA. Based on our earlier hypothesis for cutaneous reactions (Barker et al., 1990) , the early initiation phase can now be viewed as resulting from TNF-a plus the enhancing effects of histamine and cis-UCA for the up-regulation of KC ICAM-1. However, as pointed out in the original hypothesis, the subsequent amplification phase, which features the involvement of T-cell derived IFN--y , represents a substantially more potent cytokine for the further induction of KC ICAM-1. With respect to two common T-cell mediated diseases exacerbated by bacterial infections such as psoriasis and atopic dermatitis that feature mast ceIIs and cytokine activated KCs, we have recently observed that KCs can present bacterial derived superantigens to resting T cells (Nickoloff et al., 1992) . This autologous T-cell response was inhibited by antibodies directed against the CD-lla/CD-18 antigens on T cells and ICAM-1 on KCs. Thus, the ability of histamine and cis-UCA to augment TNF-a inducible KC ICAM-1 expression may convey critically important immunomodulatory signals to both KCs and T cells recruited from the circulation during inflammatory reactions of the skin. AdditionaI additive, synergistic, and antagonistic functional interactions among these three key mediators of inflammatory and immune reactions need to be investigated in other cutaneous cell types beyond KCs, and in a range of skin diseases, to more fully assess the potential therapeutic impact of these current in vitro results.
